Singapore markets open in 2 hours 39 minutes

ChemoMetec A/S (0DZ0.L)

LSE - LSE Delayed price. Currency in DKK
Add to watchlist
820.00+41.50 (+5.33%)
At close: 05:53PM BST
Currency in DKK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.20
52-week change 3-42.38%
S&P500 52-week change 325.77%
52-week high 3905.00
52-week low 3304.00
50-day moving average 3414.61
200-day moving average 3484.19

Share statistics

Avg vol (3-month) 35.19k
Avg vol (10-day) 39.2k
Shares outstanding 515.36M
Implied shares outstanding 6N/A
Float 816.77M
% held by insiders 10.00%
% held by institutions 157.47%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 36.00
Trailing annual dividend yield 30.77%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 35.81%
Operating margin (ttm)42.37%

Management effectiveness

Return on assets (ttm)19.61%
Return on equity (ttm)30.09%

Income statement

Revenue (ttm)401.54M
Revenue per share (ttm)23.06
Quarterly revenue growth (yoy)-17.70%
Gross profit (ttm)N/A
EBITDA 192.2M
Net income avi to common (ttm)143.8M
Diluted EPS (ttm)7.55
Quarterly earnings growth (yoy)-33.10%

Balance sheet

Total cash (mrq)232.15M
Total cash per share (mrq)13.34
Total debt (mrq)5.95M
Total debt/equity (mrq)1.19%
Current ratio (mrq)4.68
Book value per share (mrq)28.66

Cash flow statement

Operating cash flow (ttm)146.71M
Levered free cash flow (ttm)78.25M